GLP-1 Drugs May Cut Breast Cancer Risk

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

GLP-1 Drugs May Cut Breast Cancer Risk

Listen for free

View show details

New research reveals that popular weight-loss drugs like Ozempic and Wegovy may slash breast cancer risk by 30% in women, sparking excitement as scientists plan trials to explore their potential as cancer prevention tools.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/51b2b806155bf669

No reviews yet